版权说明 操作指南
首页 > 成果 > 详情

iNKT cell agonists as vaccine adjuvants to combat infectious diseases

认领
导出
Link by DOI
反馈
分享
QQ微信 微博
成果类型:
期刊论文
作者:
Li, Ya-Qian;Yan, Cheng;Luo, Rui;Liu, Zheng
通讯作者:
Liu, Zheng(liuz1118@ccnu.edu.cn);Luo, Rui(luorui@mail.hzau.edu.cn)
作者机构:
[Luo, Rui; Li, Ya-Qian] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.
[Yan, Cheng; Liu, Zheng] Cent China Normal Univ, Coll Chem, Key Lab Pesticide & Chem Biol, Minist Educ,Hubei Int Sci & Technol Cooperat Base, Wuhan 430079, Hubei, Peoples R China.
通讯机构:
[Rui Luo] S
[Zheng Liu] K
State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan, Hubei, 430070, PR China<&wdkj&>Key Laboratory of Pesticide & Chemical Biology of Ministry of Education, Hubei International Scientific and Technological Cooperation Base of Pesticide and Green Synthesis, College of Chemistry, Central China Normal University, Wuhan, Hubei, 430079, PR China
语种:
英文
关键词:
Adjuvant;Formulation;Infectious disease;iNKT cell;Mucosal immunity;α-galactosylceramide
期刊:
Carbohydrate Research
ISSN:
0008-6215
年:
2022
卷:
513
页码:
108527
基金类别:
This work was supported by the National Natural Science Foundation of China (No. 21977034 ), self-determined research funds of CCNU from the colleges' basic research and operation of MOE (No. CCNU20TS014 ), Fundamental Research Funds for the Central Universities (No. 2662019PY078 ), the fund from Engineering Research Center of Phosphorus Resources Development and Utilization of Ministry of Education (No. LKF2021003 ), and Program of Introducing Talents of Discipline to Universities of China (111 program, B17019 ).
机构署名:
本校为其他机构
院系归属:
化学学院
摘要:
iNKT cells are a special type of T cell that acts as a link between the innate and adaptive immune systems, with the capacity to stimulate a wide range of cell types. The glycolipid α-galactosylceramide (αGC) is a robust agonist of iNKT cells and induces the secretion of Th1- and Th2-type cytokines. αGC and its analogs are widely used as adjuvants to enhance immune responses against viral, parasitic, and bacterial pathogens. This review first discusses the challenges of using free αGC as a vaccine adjuvant to treat infectious diseases. We n...

反馈

验证码:
看不清楚,换一个
确定
取消

成果认领

标题:
用户 作者 通讯作者
请选择
请选择
确定
取消

提示

该栏目需要登录且有访问权限才可以访问

如果您有访问权限,请直接 登录访问

如果您没有访问权限,请联系管理员申请开通

管理员联系邮箱:yun@hnwdkj.com